Cargando…

US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients

The aim was to build a predictive model based on ultrasonography (US)-based deep learning model (US-DLM) and clinical features (Clin) for differentiating hepatocellular carcinoma (HCC) from other malignancy (OM) in cirrhotic patients. 112 patients with 120 HCCs and 60 patients with 61 OMs were inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hang, Jiang, Tao, Li, Qunying, Zhang, Chao, Zhang, Cong, Liu, Yajing, Cao, Jing, Sun, Yu, Jin, Peile, Luo, Jiali, Pan, Minqiang, Huang, Pintong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217663/
https://www.ncbi.nlm.nih.gov/pubmed/34168992
http://dx.doi.org/10.3389/fonc.2021.672055
_version_ 1783710639221374976
author Zhou, Hang
Jiang, Tao
Li, Qunying
Zhang, Chao
Zhang, Cong
Liu, Yajing
Cao, Jing
Sun, Yu
Jin, Peile
Luo, Jiali
Pan, Minqiang
Huang, Pintong
author_facet Zhou, Hang
Jiang, Tao
Li, Qunying
Zhang, Chao
Zhang, Cong
Liu, Yajing
Cao, Jing
Sun, Yu
Jin, Peile
Luo, Jiali
Pan, Minqiang
Huang, Pintong
author_sort Zhou, Hang
collection PubMed
description The aim was to build a predictive model based on ultrasonography (US)-based deep learning model (US-DLM) and clinical features (Clin) for differentiating hepatocellular carcinoma (HCC) from other malignancy (OM) in cirrhotic patients. 112 patients with 120 HCCs and 60 patients with 61 OMs were included. They were randomly divided into training and test cohorts with a 4:1 ratio for developing and evaluating US-DLM model, respectively. Significant Clin predictors of OM in the training cohort were combined with US-DLM to build a nomogram predictive model (US-DLM+Clin). The diagnostic performance of US-DLM and US-DLM+Clin were compared with that of contrast enhanced magnetic resonance imaging (MRI) liver imaging and reporting system category M (MRI LR-M). US-DLM was the best independent predictor for evaluating OMs, followed by clinical information, including high cancer antigen 199 (CA199) level and female. The US-DLM achieved an AUC of 0.74 in the test cohort, which was comparable with that of MRI LR-M (AUC=0.84, p=0.232). The US-DLM+Clin for predicting OMs also had similar AUC value (0.81) compared with that of LR-M+Clin (0.83, p>0.05). US-DLM+Clin obtained a higher specificity, but a lower sensitivity, compared to that of LR-M +Clin (Specificity: 82.6% vs. 73.9%, p=0.007; Sensitivity: 78.6% vs. 92.9%, p=0.006) for evaluating OMs in the test set. The US-DLM+Clin model is valuable in differentiating HCC from OM in the setting of cirrhosis.
format Online
Article
Text
id pubmed-8217663
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82176632021-06-23 US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients Zhou, Hang Jiang, Tao Li, Qunying Zhang, Chao Zhang, Cong Liu, Yajing Cao, Jing Sun, Yu Jin, Peile Luo, Jiali Pan, Minqiang Huang, Pintong Front Oncol Oncology The aim was to build a predictive model based on ultrasonography (US)-based deep learning model (US-DLM) and clinical features (Clin) for differentiating hepatocellular carcinoma (HCC) from other malignancy (OM) in cirrhotic patients. 112 patients with 120 HCCs and 60 patients with 61 OMs were included. They were randomly divided into training and test cohorts with a 4:1 ratio for developing and evaluating US-DLM model, respectively. Significant Clin predictors of OM in the training cohort were combined with US-DLM to build a nomogram predictive model (US-DLM+Clin). The diagnostic performance of US-DLM and US-DLM+Clin were compared with that of contrast enhanced magnetic resonance imaging (MRI) liver imaging and reporting system category M (MRI LR-M). US-DLM was the best independent predictor for evaluating OMs, followed by clinical information, including high cancer antigen 199 (CA199) level and female. The US-DLM achieved an AUC of 0.74 in the test cohort, which was comparable with that of MRI LR-M (AUC=0.84, p=0.232). The US-DLM+Clin for predicting OMs also had similar AUC value (0.81) compared with that of LR-M+Clin (0.83, p>0.05). US-DLM+Clin obtained a higher specificity, but a lower sensitivity, compared to that of LR-M +Clin (Specificity: 82.6% vs. 73.9%, p=0.007; Sensitivity: 78.6% vs. 92.9%, p=0.006) for evaluating OMs in the test set. The US-DLM+Clin model is valuable in differentiating HCC from OM in the setting of cirrhosis. Frontiers Media S.A. 2021-06-08 /pmc/articles/PMC8217663/ /pubmed/34168992 http://dx.doi.org/10.3389/fonc.2021.672055 Text en Copyright © 2021 Zhou, Jiang, Li, Zhang, Zhang, Liu, Cao, Sun, Jin, Luo, Pan and Huang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhou, Hang
Jiang, Tao
Li, Qunying
Zhang, Chao
Zhang, Cong
Liu, Yajing
Cao, Jing
Sun, Yu
Jin, Peile
Luo, Jiali
Pan, Minqiang
Huang, Pintong
US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients
title US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients
title_full US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients
title_fullStr US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients
title_full_unstemmed US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients
title_short US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients
title_sort us-based deep learning model for differentiating hepatocellular carcinoma (hcc) from other malignancy in cirrhotic patients
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217663/
https://www.ncbi.nlm.nih.gov/pubmed/34168992
http://dx.doi.org/10.3389/fonc.2021.672055
work_keys_str_mv AT zhouhang usbaseddeeplearningmodelfordifferentiatinghepatocellularcarcinomahccfromothermalignancyincirrhoticpatients
AT jiangtao usbaseddeeplearningmodelfordifferentiatinghepatocellularcarcinomahccfromothermalignancyincirrhoticpatients
AT liqunying usbaseddeeplearningmodelfordifferentiatinghepatocellularcarcinomahccfromothermalignancyincirrhoticpatients
AT zhangchao usbaseddeeplearningmodelfordifferentiatinghepatocellularcarcinomahccfromothermalignancyincirrhoticpatients
AT zhangcong usbaseddeeplearningmodelfordifferentiatinghepatocellularcarcinomahccfromothermalignancyincirrhoticpatients
AT liuyajing usbaseddeeplearningmodelfordifferentiatinghepatocellularcarcinomahccfromothermalignancyincirrhoticpatients
AT caojing usbaseddeeplearningmodelfordifferentiatinghepatocellularcarcinomahccfromothermalignancyincirrhoticpatients
AT sunyu usbaseddeeplearningmodelfordifferentiatinghepatocellularcarcinomahccfromothermalignancyincirrhoticpatients
AT jinpeile usbaseddeeplearningmodelfordifferentiatinghepatocellularcarcinomahccfromothermalignancyincirrhoticpatients
AT luojiali usbaseddeeplearningmodelfordifferentiatinghepatocellularcarcinomahccfromothermalignancyincirrhoticpatients
AT panminqiang usbaseddeeplearningmodelfordifferentiatinghepatocellularcarcinomahccfromothermalignancyincirrhoticpatients
AT huangpintong usbaseddeeplearningmodelfordifferentiatinghepatocellularcarcinomahccfromothermalignancyincirrhoticpatients